Neurosurgery

Vycor Medical Posts Operating Profit in Q1 2026 as International Sales Drive Revenue Growth

Vycor Medical Posts Operating Profit in Q1 2026 as International Sales Drive Revenue Growth

Vycor Medical reported a 5% revenue increase to $458,540 for Q1 2026, achieving an operating profit of $45,808 compared to a loss last year, driven by international expansion and supported by new clinical studies on its ViewSite Brain Access System.

May 15, 2026
Vycor Medical Reports Significant Growth in Revenue and Operating Profit for First Half of 2025

Vycor Medical Reports Significant Growth in Revenue and Operating Profit for First Half of 2025

Vycor Medical, Inc. announces a notable increase in revenue and operating profit for the first six months of 2025, driven by international expansion and advancements in its neurosurgical and vision rehabilitation technologies.

August 8, 2025
Prosidio Endoscope Facilitates Historic Endoscopic Pituitary Surgery in The Gambia

Prosidio Endoscope Facilitates Historic Endoscopic Pituitary Surgery in The Gambia

The first-ever endoscopic pituitary surgery in The Gambia, enabled by Prosidio's advanced endoscope, marks a significant advancement in neurosurgical care for the region.

July 1, 2025